Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel With Prednisone With or Without Maintenance GM-CSF

R. Aggarwal,T. Beer,V. Weinberg,C. Higano,M. Taplin,C. Ryan,A. Lin,J. Alumkal,J. Graff,L. Nordquist,Isheen Herrera,E. Small
DOI: https://doi.org/10.1016/j.clgc.2014.12.004
IF: 3.121
2015-06-01
Clinical Genitourinary Cancer
Abstract:
What problem does this paper attempt to address?